THE PREVALENCE OF PERIPHERAL VASCULAR-DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA

被引:21
|
作者
KROON, AA
AJUBI, N
VANASTEN, WNJC
STALENHOEF, AFH
机构
[1] UNIV NIJMEGEN HOSP,DEPT INTERNAL MED,6500 HB NIJMEGEN,NETHERLANDS
[2] UNIV NIJMEGEN HOSP,DEPT CARDIOTHORAC SURG,CLIN VASC LAB,6500 HB NIJMEGEN,NETHERLANDS
关键词
ATHEROSCLEROSIS; CORONARY HEART DISEASE; DOPPLER SPECTRUM ANALYSIS; FAMILIAL HYPERCHOLESTEROLEMIA; PERIPHERAL VASCULAR DISEASE;
D O I
10.1111/j.1365-2796.1995.tb01223.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. In patients with familial hypercholesterolaemia (FH), the prevalence of haemodynamically significant peripheral vascular disease (PVD) was measured in relation to lipoproteins, general risk factors and the presence of coronary artery disease (CAD). Design. A case control study. Setting. The outpatient lipid clinic of a university hospital (tertiary referral centre), Subjects. Patients with heterozygous FH [n = 68; age 45.8 +/- 11.6 years; untreated LDL-cholesterol 9.2 +/- 2.0 mmol L(-1)] were compared with control subjects matched for gender, age, weight, smoking and presence of hypertension [n = 27; age 44.0 years; LDL-cholesterol 3.8 +/- 1.3 mmol L(-1)]. Main outcome measures. PVD was assessed during cholesterol-lowering treatment using ankle/arm blood pressure ratios and analyses of Doppler-derived blood now velocities in the femoral artery at rest and during reactive hyperaemia. The diagnosis of CAD was assessed clinically, Results. Haemodynamically significant PVD was found in 21 (31%) FH patients and in one (3.7%) control subject, predominantly localized in the femoro-popliteal vessels. CAD was present in 30 (44.1%) FH patients and in one (3.7%) control subject, PVD could be demonstrated in 50% of FH patients with CAD [relative risk 3.2 (95% CI 1.4-7.2)] and in 19% as the first manifestation of vascular disease. Males and females were equally affected. Mean arterial blood pressure of FH patients with PVD was higher compared to FH patients without PVD. Conclusions. Haemodynamically significant PVD appears to be more prevalent in FH patients than is generally assumed, especially in those with CAD, A relation with lipoprotein levels could not be demonstrated.
引用
收藏
页码:451 / 459
页数:9
相关论文
共 50 条
  • [31] ILOPROST IN PERIPHERAL VASCULAR-DISEASE
    KRAIS, T
    MULLER, B
    CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (02): : 158 - 171
  • [32] ANGIOSCOPY IN PERIPHERAL VASCULAR-DISEASE
    CHEVALIER, JM
    GAYRAL, M
    REIGNER, B
    ENON, B
    LESCALIE, F
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1991, 84 (11): : 1705 - 1709
  • [33] PREVALENCE OF HYPERLIPOPROTEINEMIA IN VASCULAR-DISEASE
    LAWRIE, TDV
    BALLANTYNE, D
    MORGAN, HG
    LORIMER, AR
    JUBB, JS
    POSTGRADUATE MEDICAL JOURNAL, 1975, 51 : 7 - 15
  • [34] PREVALENCE AND DIAGNOSIS OF PERIPHERAL VASCULAR-DISEASE IN ELDERLY PEOPLE LIVING AT HOME
    DUNCAN, G
    WILSON, JA
    MACLENNAN, WJ
    JOURNAL OF CLINICAL AND EXPERIMENTAL GERONTOLOGY, 1990, 12 (04): : 229 - 239
  • [35] VASCULAR REACTIVITY IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    HARRIS, LM
    FAGGIOLI, GL
    SHAH, R
    KOERNER, N
    LILLIS, L
    DANDONA, P
    IZZO, JL
    SNYDER, B
    RICOTTA, JJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (03): : 207 - 212
  • [36] SEROTONIN, HISTAMINE AND PLATELETS IN VASCULAR-DISEASE WITH SPECIAL REFERENCE TO PERIPHERAL VASCULAR-DISEASE
    BARRADAS, MA
    MIKHAILIDIS, DP
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1992, 25 (11) : 1063 - 1076
  • [37] ANTITHROMBOTIC THERAPY IN PERIPHERAL VASCULAR-DISEASE
    GENTON, E
    CLAGETT, GP
    SALZMAN, EW
    CHEST, 1986, 89 (02) : S75 - S81
  • [38] ANTITHROMBOTIC THERAPY OF PERIPHERAL VASCULAR-DISEASE
    NENCI, GG
    PLATELETS, 1993, 4 : 21 - 23
  • [39] PROGRESS IN THE MANAGEMENT OF PERIPHERAL VASCULAR-DISEASE
    BLAU, S
    KERSTEIN, MD
    VASCULAR SURGERY, 1982, 16 (03): : 172 - 184
  • [40] PERIPHERAL VASCULAR-DISEASE - BENEFITS OF EXERCISE
    ERNST, E
    SPORTS MEDICINE, 1991, 12 (03) : 149 - 151